Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICBN Block for Tourniquet Pain
NCT03797924Phase 1Completed
- Sponsor
- University of Florida
- Start
- Apr 2019
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ropivacaine (2 arms), sponsored by University of Florida. Primary endpoint: Incidence of tourniquet pain reported by the patient on a Descriptor Differential Scale of Pain Intensity (DDSI). Started Apr 2019; status: completed.
02
Drugs
ropivacaine
Beyond the preview
Go deeper on NCT03797924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03797924.